ACTU Competitors & Alternatives
Compare Actuate Therapeutics, Inc. Common stock with similar stocks in the same industry
Biotechnology
ACTU
Main Stock$1.73
Tradestie Score
53
Market Cap
$161.08M
Analyst Upside
+476.7%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACHV
Achieve Life Sciences, Inc.
|
$6.31
|
$158.43M | - | 57 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$18.29
|
$154.27M | - | 51 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$13.24
|
$133.50M | - | 59 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.29
|
$114.01M | - | 60 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.80
|
$110.20M | - | 62 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.21
|
$71.69M | - | 54 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.68
|
$67.94M | - | 62 | Compare |
|
ACCL
ACCL
|
$1.88
|
$26.50M | 47.5 | 64 | Compare |
|
ACTL
ACTL
|
- | - | - | - | Compare |
|
CPWR
CPWR
|
- | - | - | - | Compare |
More ACTU Analysis
Data updated: Jul 15, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry